Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Open access
Yoshihara, Kosuke, Tsunoda, Tatsuhiko, Shigemizu, Daichi, Fujiwara, Hiroyuki, Hatae, Masayuki, Fujiwara, Hisaya, Masuzaki, Hideaki, Katabuchi, Hidetaka, Kawakami, Yosuke, Okamoto, Aikou, Nogawa, Takayoshi, Matsumura, Noriomi, Udagawa, Yasuhiro, Saito, Tsuyoshi, Itamochi, Hiroaki, Takano, Masashi, Miyagi, Etsuko, Sudo, Tamotsu, Ushijima, Kimio, Iwase, Haruko, Seki, Hiroyuki, Terao, Yasuhisa, Enomoto, Takayuki, Mikami, Mikio, Akazawa, Kohei, Tsuda, Hitoshi, Moriya, Takuya, Tajima, Atsushi, Inoue, Ituro, Tanaka, Kenichi · 2012 · Clinical Cancer Research

Abstract

Purpose: High-grade serous ovarian cancers are heterogeneous not only in terms of clinical outcome but also at the molecular level. Our aim was to establish a novel risk classification system based on a gene expression signature for predicting overall survival, leading to suggesting novel therapeutic strategies for high-risk patients. Experimental Design: In this large-scale cross-platform study of six microarray data sets consisting of 1,054 ovarian cancer patients, we developed a gene expression signature for predicting overall survival by applying elastic net and 10-fold cross-validation to a Japanese data set A (n = 260) and evaluated the signature in five other data sets. Subsequently, we investigated differences in the biological characteristics between high- and low-risk ovarian cancer groups. Results: An elastic net analysis identified a 126-gene expression signature for predicting overall survival in patients with ovarian cancer using the Japanese data set A (multivariate analysis, P = 4 × 10−20). We validated its predictive ability with five other data sets using multivariate analysis (Tothill's data set, P = 1 × 10−5; Bonome's data set, P = 0.0033; Dressman's data set, P = 0.0016; TCGA data set, P = 0.0027; Japanese data set B, P = 0.021). Through gene ontology and pathway analyses, we identified a significant reduction in expression of immune-response–related genes, especially on the antigen presentation pathway, in high-risk ovarian cancer patients. Conclusions: This risk classification based on the 126-gene expression signature is an accurate predictor of clinical outcome in patients with advanced stage high-grade serous ovarian cancer and has the potential to develop new therapeutic strategies for high-grade serous ovarian cancer patients. Clin Cancer Res; 18(5); 1374–85. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-2725

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 189

Metadata

Authors
Yoshihara, K., Tsunoda, T., Shigemizu, D., Fujiwara, H., Hatae, M., Fujiwara, H., Masuzaki, H., Katabuchi, H., Kawakami, Y., Okamoto, A., Nogawa, T., Matsumura, N., Udagawa, Y., Saito, T., Itamochi, H., Takano, M., Miyagi, E., Sudo, T., Ushijima, K., Iwase, H., Seki, H., Terao, Y., Enomoto, T., Mikami, M., Akazawa, K., Tsuda, H., Moriya, T., Tajima, A., Inoue, I., & Tanaka, K.
Venue
Clinical Cancer Research
Published
2012-03-01
Volume
18
Issue
5
Pages
1374-1385
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2104765303
Cited by
189
References
6
FWCI
13.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-2725
The paper
Yoshihara, K., Tsunoda, T., Shigemizu, D., Fujiwara, H., Hatae, M., Fujiwara, H., Masuzaki, H., Katabuchi, H., Kawakami, Y., Okamoto, A., Nogawa, T., Matsumura, N., Udagawa, Y., Saito, T., Itamochi, H., Takano, M., Miyagi, E., Sudo, T., Ushijima, K., . . . Tanaka, K. (2012). High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-2725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.